The Board of Directors of
As executive chairman, I will focus on strategic partnerships. Transforming healthcare by industrializing regenerative medicine and the manufacturing of cell-based therapies is an ambitious project. Besides academic alliances, it will require industrial and regulatory partnerships involving major software companies, life science tools companies and regulatory agencies.
With my previous background in senior positions in companies during rapid growth, I feel well equipped to take on the daily leadership and drive the two objectives the Board has presented me with: further increase sales and develop PHI's HoloMonitor technology in regenerative medicine. Together with our partners, we are setting the standards for automated quality control systems in regenerative medicine.
This disclosure contains information that
For additional information, please contact:
E-mail: ir@phiab.se
Web: www.phiab.com - Live cell imaging & analysis
https://news.cision.com/phase-holographic/r/phi-focuses-on-biomanufacturing---appoints-new-ceo-and-chairman,c3698757
https://mb.cision.com/Main/11597/3698757/1784840.pdf
(c) 2023 Cision. All rights reserved., source